IL-1β as a major cytokine induced by inflammasome activation [52], was also upregulated in patients with carcinoma (Group 1) in addition to Lyme borreliosis patients with neurological diseases (Group 3), and in patients with multiple additional infections (Group 4). The gene discussed is IL1B; the disease is carcinoma.